AMIA joined more than 500 organizations in urging Congress to provide $51.3 billion for the National Institutes of Health in FY 2027 and ensure appropriated funds are used as intended. The coalition warns that funding disruptions, grant delays, and workforce instability threaten biomedical research, scientific innovation, and future medical breakthroughs.
AMIA submitted comments on CMS’s proposed drug prior authorization rule, supporting FHIR-based interoperability and electronic prior authorization modernization. AMIA urged CMS to reduce administrative burden, improve medication access, strengthen transparency and standards alignment, enhance API performance and patient access, establish safeguards for AI-enabled prior authorization, and advance long-term prior authorization […]